Human neutrophil lipocalin (HNL) as a biomarker of acute infections

Distinction between bacterial and viral infections by serum measurement of human neutrophil lipocalin (HNL) and the impact of antibody selection

(2016) Zhang Yu et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Antimicrobial resistance—a threat to the world’s sustainable development

(2016) Dušan Jasovský et al.   UPSALA JOURNAL OF MEDICAL SCIENCES

The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases

(2015) Vanessa Abella et al.   BIOMARKERS

Human Neutrophil Lipocalin as a Superior Diagnostic Means To Distinguish between Acute Bacterial and Viral Infections

(2015) Per Venge et al.   Clinical and Vaccine Immunology

Human neutrophil lipocalin in fMLP-activated whole blood as a diagnostic means to distinguish between acute bacterial and viral infections

(2015) Per Venge et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Antibiotic Resistance — Problems, Progress, and Prospects

(2014) Carl Nathan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antibiotic resistance—the need for global solutions

(2013) Ramanan Laxminarayan et al.   LANCET INFECTIOUS DISEASES

Immunoassays distinguishing between HNL/NGAL released in urine from kidney epithelial cells and neutrophils

(2012) Johan Mårtensson et al.   CLINICA CHIMICA ACTA

The Origin of Multiple Molecular Forms in Urine of HNL/NGAL

(2010) L. Cai et al.   Clinical Journal of the American Society of Nephrology

Assays of urine levels of HNL/NGAL in patients undergoing cardiac surgery and the impact of antibody configuration on their clinical performances

(2009) Linjun Cai et al.   CLINICA CHIMICA ACTA

Neutrophil and monocyte receptor expression in uncomplicated and complicated influenza A infection with pneumonia

(2008) Karlis Pauksens et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES